Novel Coronavirus COVID-19 Outbreak.

  • The latest reported figures on COVID-19 including the number of confirmed cases by country and a detailed map of distribution of cases are available from the World Health Organization (WHO). WHO global situation reports are available on the WHO website.
  • Further information on the COVID-19 outbreak situation is also available through the European Centre for Disease Prevention and Control (ECDC)
  • Guidance from HPSC is available at

Situation update:

There are two confirmed cases of COVID-19 in Ireland. Both patients were diagnosed in the East of Ireland, following travel to Italy. Identification and follow up of contacts is underway by public health services.

Since 31 December 2019 and as of 3 March 2020, 90 663 cases of COVID-19 (in accordance with the applied case definitions in the affected countries) have been reported globally, including 3 124 deaths. The deaths have been reported from China (2 946), Iran (66), Italy (52), South Korea (34), on an international conveyance in Japan (6), Japan (6), the United States of America (6), France (3), Australia (1), the Philippines (1), San Marino (1), Taiwan (1) and Thailand (1).

Cases have been reported in the following continents:

Africa: Algeria (3), Egypt (2), Morocco (1), Nigeria (1), Senegal (1) and Tunisia (1).

Asia: China (80 261), South Korea (4 812), Iran (1 501), Japan (254), Singapore (108), Kuwait (56), Bahrain (47), Thailand (43), Taiwan (41), Malaysia (29), Iraq (21), United Arab Emirates (21), Vietnam (16), Lebanon (13), Israel (10), Oman (7), India (5), Pakistan (4), Philippines (3), Qatar (3), Indonesia (2), Afghanistan (1), Cambodia (1), Jordan (1), Nepal (1), Saudi Arabia (1) and Sri Lanka (1).

America: United States of America (103), Canada (27), Ecuador (7), Mexico (5), Brazil (2) and Dominican Republic (1).

Europe: Italy (1 835), France (178), Germany (157), Spain (114), United Kingdom (40), Switzerland (30), Norway (25), Austria (18), Netherlands (18), Sweden (15), Belgium (8), Croatia (8), San Marino (8), Greece (7), Finland (6), Iceland (6), Czech Republic (5), Denmark (5), Azerbaijan (3), Georgia (3), Romania (3), Russia (3), Portugal (2), Andorra (1), Armenia (1), Belarus (1), Estonia (1), Ireland (1), Latvia (1), Lithuania (1), Luxembourg (1), Monaco (1) and North Macedonia (1).

Oceania: Australia (33) and New Zealand (1).

Other: Cases on an international conveyance in Japan (705).

Further information is available on the ECDC website.

ECDC risk assessment:

On 3rd March, ECDC published an updated report on the situation; Current risk assessment on the novel

On the basis of the information currently available, ECDC considers that:

  • The risk associated with COVID-19 infection for people in the EU/EEA and UK is currently considered to be moderate to high.
  • The risk of acquiring the disease for people from the EU/EEA and the UK travelling/resident in areas with no cases, or multiple imported cases, or limited local transmission, is currently considered low to moderate.
  • The risk for people from the EU/EEA and the UK travelling/resident in areas with more widespread local transmission is currently considered to be high.
  • The risk of the occurrence of clusters associated with COVID-19 in other countries in the EU/EEA and the UK is currently considered moderate to high.
  • The risk of widespread and sustained transmission of COVID-19 in the EU/EEA and the UK in the coming weeks is moderate to high with more countries reporting more cases and clusters.
  • The risk for healthcare system capacity in the EU/EEA and the UK in the coming weeks is considered moderate to high.

The SARS-CoV-2 virus that causes COVID-19 is a new strain of coronavirus that has not been previously identified in humans. Outbreaks of novel virus infections among people are always of public health concern, especially when there’s little knowledge about the characteristics of the virus, how it spreads between people, how severe are the resulting infections and how to treat them.

Further information from HPSC is available at


This website uses cookies in order to improve the site and user experience. By continuing to use it, you agree to our Privacy Policy.